Results 141 to 150 of about 25,223 (248)

Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study. [PDF]

, 2019
OBJECTIVE: To determine the effect of erenumab, a human monoclonal antibody targeting the calcitonin gene-related peptide receptor, on health-related quality of life (HRQoL), headache impact, and disability in patients with chronic migraine (CM). METHODS:
Cheng, Sunfa, Desai, Pooja, Lenz, Robert, Leonardi, Dean K., Lipton, Richard B., Mikol, Daniel D., Nilsen, Jon, Reuter, Uwe, Silberstein, Stephen, Stewart, Walter F., Tepper, Stewart J.   +10 more
core   +1 more source

Working as a Registered Nurse During Menopause—A Multiple Methods Study

Journal of Advanced Nursing, Volume 82, Issue 5, Page 5419-5429, May 2026.
ABSTRACT Aim To describe the experiences of Finnish registered nurses aged 45 and over working during menopause. Design Multiple methods study. Methods The data were collected from Finnish registered nurses aged 45 and over, using two different methods. Quantitative data (n = 3487), collected in January 2023, were analysed using descriptive statistical
Siranko Heta, Stolt Minna, Hult Marja
wiley   +1 more source

Biologics for episodic and chronic migraines

Canadian Family Physician, 2021
Sandra, Trkulja, Trudy, Huyghebaert, Joey, Ton, Clark, Svrcek   +3 more
openaire   +2 more sources

Functional evaluation of the auditory brainstem in migraine patients using ABR and MLD tests

The Egyptian Journal of Otolaryngology
Background Migraine is a prevalent neurological disorder commonly associated with sensory disturbances, including phonophobia. These symptoms suggest possible involvement of central auditory pathways, particularly at the brainstem level, yet objective ...
Mohammad S. Ali, Hayam Abdel-Tawab, Ibrahim H. Abd-Elhmid, Soliman S. Ghanem, Hossam A. Hussein, Eman A. Elhamrawy, Tamer El-Esawy Abdel-Moaaty, Ahmed I. Abbas   +7 more
doaj   +1 more source

Galcanezumab for the preventive treatment of episodic and chronic migraine in real life: A prospective multicenter study in Colombia and Mexico, including effects on anxiety and depression—on behalf of ASOLAC

Cephalalgia Reports
Background Galcanezumab is a therapeutic option for individuals with high-frequency episodic and chronic migraine. To date, there is no information regarding treatment results for Colombia and Mexico.
Joe Muñoz-Cerón, Karina Vélez-Jiménez, Stephanía Bohórquez-Valderrama, Ildefonso Rodríguez-Leyva, Natalia Hernández, Loren Gallo-Eugenio, Claudia Moreno-Rodríguez, Juan Jiménez-Jaramillo, Carolina Guerra-Posada, Marta Ramos-Romero, Rafael Bernal-Cobo, Yessica Rojas-Villegas, Paula Cavanzo-Henao, Reydmar López-González, Daniela Gómez-Barrera,   +15 more
doaj   +1 more source

Episodic disorders: channelopathies and beyond. [PDF]

, 2015
Ptáček, Louis J
core   +1 more source

Lacosamide Versus Propranolol in Episodic Migraine, a Randomized Controlled Double-blinded Trial. [PDF]

Mol Neurobiol
Zeinhom MG, Rezk SG, Mohamed AM, Ahmed SR.   +3 more
europepmc   +1 more source

Vivid Dreams and Nightmares as an Adverse Effect of Beta-Blockers in the Treatment of Episodic Migraine. [PDF]

Case Rep Neurol Med
Silva-Rosas CR, Angus-Leppan H, Quijada AH, Briceño AG.   +3 more
europepmc   +1 more source

Prefrontal dysregulation of interoceptive and emotional processing in episodic migraine: a task-based fMRI study. [PDF]

J Headache Pain
Li Y, Liu R, Lin C, Duan C, Xiong Z, Guo Z, Li X, Liu X, Cao J, Wang Y.   +9 more
europepmc   +1 more source

Sleep Domain Predictors of Headache-Related Disability in Episodic Migraine and Cluster Headache: A Prospective Observational Cohort Study. [PDF]

J Clin Med
Aydın Ş, Aşkın Turan S.
europepmc   +1 more source